Patents by Inventor Chuan-Tien Hung

Chuan-Tien Hung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting virus infection and replication
    Patent number: 11679102
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: June 20, 2023
    Assignee: Chang Gung University
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang
  • Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
    Patent number: 11634464
    Abstract: Disclosed herein are recombinant polypeptides derived from FBP1 and FBP2. Also disclosed herein are recombinant expression vectors and recombinant host cells for producing the aforesaid recombinant polypeptides. The recombinant polypeptides are proven to be useful and effective in producing a picornavirus with a type I internal ribosome entry site (IRES), so as to facilitate the preparation of a viral vaccine.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: April 25, 2023
    Assignee: CHANG GUNG UNIVERSITY
    Inventors: Shin-Ru Shih, Yu-An Kung, Chuan-Tien Hung
  • METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
    Publication number: 20210386725
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of pioglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with pioglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG
  • METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
    Publication number: 20210386726
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of rosiglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with rosiglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG
  • METHOD FOR INHIBITING VIRUS INFECTION AND REPLICATION
    Publication number: 20210386702
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 16, 2021
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang
  • RECOMBINANT POLYPEPTIDES DERIVED FROM FBP1 AND FBP2 AND USES OF THE SAME
    Publication number: 20200317739
    Abstract: Disclosed herein are recombinant polypeptides derived from FBP1 and FBP2. Also disclosed herein are recombinant expression vectors and recombinant host cells for producing the aforesaid recombinant polypeptides. The recombinant polypeptides are proven to be useful and effective in producing a picornavirus with a type I internal ribosome entry site (IRES), so as to facilitate the preparation of a viral vaccine.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Shin-Ru Shih, Yu-An Kung, Chuan-Tien Hung
  • Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
    Patent number: 10730920
    Abstract: Disclosed herein are recombinant polypeptides derived from FBP1 and FBP2. Also disclosed herein are recombinant expression vectors and recombinant host cells for producing the aforesaid recombinant polypeptides. The recombinant polypeptides are proven to be useful and effective in producing a picornavirus with a type I internal ribosome entry site (IRES), so as to facilitate the preparation of a viral vaccine.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: August 4, 2020
    Assignee: CHANG GUNG UNIVERSITY
    Inventors: Shin-Ru Shih, Yu-An Kung, Chuan-Tien Hung
  • RECOMBINANT POLYPEPTIDES DERIVED FROM FBP1 AND FBP2 AND USES OF THE SAME
    Publication number: 20180305422
    Abstract: Disclosed herein are recombinant polypeptides derived from FBP1 and FBP2. Also disclosed herein are recombinant expression vectors and recombinant host cells for producing the aforesaid recombinant polypeptides. The recombinant polypeptides are proven to be useful and effective in producing a picornavirus with a type I internal ribosome entry site (IRES), so as to facilitate the preparation of a viral vaccine.
    Type: Application
    Filed: April 18, 2018
    Publication date: October 25, 2018
    Inventors: Shin-Ru Shih, Yu-An Kung, Chuan-Tien Hung